KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Long-Term Investments (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Long-Term Investments for 16 consecutive years, with $396.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Investments rose 23.75% to $396.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $396.0 million, a 23.75% increase, with the full-year FY2025 number at $396.0 million, up 23.75% from a year prior.
  • Long-Term Investments was $396.0 million for Q4 2025 at Bristol Myers Squibb, down from $406.0 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $406.0 million in Q3 2025 to a low of $46.0 million in Q3 2021.
  • A 4-year average of $303.1 million and a median of $350.5 million in 2024 define the central range for Long-Term Investments.
  • Peak YoY movement for Long-Term Investments: tumbled 90.71% in 2021, then grew 23.75% in 2025.
  • Bristol Myers Squibb's Long-Term Investments stood at $46.0 million in 2021, then soared by 691.3% to $364.0 million in 2023, then decreased by 12.09% to $320.0 million in 2024, then grew by 23.75% to $396.0 million in 2025.
  • Per Business Quant, the three most recent readings for BMY's Long-Term Investments are $396.0 million (Q4 2025), $406.0 million (Q3 2025), and $344.0 million (Q1 2025).